Rare diseases refer to over 7,000 different known health conditions that together affect up to…
Science parks are areas designed to drive technological innovation forward by connecting businesses, knowledge &…
Cell and gene therapies have proven to be promising treatments for cancers and genetic diseases,…
Chimeric antigen receptor-T cell (CAR-T) therapy is an exciting treatment modality for blood cancers that…
Large-panel cancer cell line screening can help find the right fit between a specific cancer…
Chimeric antigen receptor (CAR) cell therapy offers hope where other cancer therapies have failed. However,…
Artificial intelligence (AI) has become a part of everyday modern life and continues to generate…
The question of whether to partner with another company is critical to the long-term development…
Update (21/11/2019): The Swedish biotech BioArctic has terminated the clinical development of a biodegradable implant…
Update (27/09/2018): New investment from Dutch venture capital fund Innovation Industries brings A-Mansia's Series A…
Update (10/09/2018): RSP Systems has raised an additional €3.85M that raises the total amount of…
Novo Nordisk acquired the UK biotech Ziylo, which develops glucose-responsive insulin treatments for diabetes that…
